Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Treating patients in the LGBTQIA+ community: ‘The key is cultural humility, kindness’ Kate Burba
-
- Displays of inclusivity ‘not enough’ in the absence of adequate LGBTQIA+ care training Nikki Duong, MD
- Colonoscopy screening gap ‘could potentially be extended’ to 15 years for average-risk CRC Kate Burba
- CRC incidence on the rise among younger women, ‘demands heightened attention’ Kate Burba
- CRC rarely found in older adults at surveillance colonoscopy regardless of polyp history Kate Burba
- ‘Encouraging’ data: GLP-1RAs linked to lower risk for cirrhosis in MASLD, type 2 diabetes Kate Burba
- FDA approves ColoSense stool RNA test to detect colorectal cancer in average-risk adults
- FDA approves high-concentration, citrate-free form of interchangeable biosimilar Cyltezo
- Food insecurity boosts fibrosis odds in HIV with diabetes, lowers MASLD odds in HIV alone Kate Burba
-
- GLP-1RA use in MAFLD, obesity lowers mortality, ‘provides cardiovascular benefits’ Monica Stonehill
- Health care professionals ‘thrilled’ with approval of first treatment for MASH Creation Healthcare
- Nearly 60 million individuals aged 45 to 85 years are eligible for CRC screening in the US Kate Burba
- Prompt identification of new-onset diabetes may aid early detection of pancreatic cancer Kate Burba
- ‘Provider recommendation critical’ to colonoscopy uptake for non-Hispanic Black adults Robert Stott
- SEQUENCE: Skyrizi outperforms for Crohn’s remission; Stelara ‘still remains on the table’ Robert Stott
- Takeda’s Entyvio snags second FDA approval as ‘subcutaneous option’ for Crohn’s disease
- VIDEO: Greater reduction in parenteral support with apraglutide vs. placebo in SBS-IF Kishore R. Iyer, MBBS; Monica Stonehill
-
- VIDEO: New book a ‘holistic toolbox’ of nutritional, behavioral strategies for treating IBS Megan E. Riehl, PsyD, AGAF; Kate Scarlata, MPH, RDN; Kate Burba
- VIDEO: Women, Black patients underrepresented in US-based clinical trials for LT Kate Burba; Saqr Alsakarneh, MD, MSc
- VIDEO: ‘You can make a big impact,’ tackle medical misinformation with social media Wendi LeBrett, MD; Monica Stonehill
- Vonoprazan noninferior to PPIs in preventing 30-day rebleeding in high-risk peptic ulcers Kate Burba